Form 8-K Oncothyreon Inc. For: Apr 21

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2015

 

 

ONCOTHYREON INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-33882		26-0868560
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2601 Fourth Avenue, Suite 500

Seattle, Washington 98121

(Address of principal executive offices, including zip code)

(206) 801-2100

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 8.01 Other Events.

Dr. Jay Venkatesan notified Oncothyreon Inc. (the “Company”) of his intention to resign as the Executive Vice President and General Manager of the Company, effective May 15, 2015, to accept a position as Chief Executive Officer of a private biotechnology company. In connection with his resignation from the Company, Dr. Venkatesan entered into a lock-up agreement with the Company that prohibits him from selling, pledging, assigning or otherwise transferring any shares beneficially owned by him for 180 days after his resignation, subject to certain exceptions.

 

2

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 21, 2015

 

3

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wolverine Worldwide Announces First Quarter Fiscal 2024 Conference Call for May 8, 2024
• SSRM INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that SSR Mining Inc. Investors with Substantial Losses Have Opportunity to Lead Case
• Fixing of coupon rates - Nykredit Realkredit A/S